Kissei Pharmaceutical Co., Ltd. (4547.T)
JPY 3515.0
(0.14%)
JPY 3515.0
(0.14%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 4.01 Billion JPY | 455.8% |
| 2022 | -1.12 Billion JPY | 19.47% |
| 2021 | -1.4 Billion JPY | -193.16% |
| 2020 | 1.5 Billion JPY | -18.96% |
| 2019 | 1.85 Billion JPY | -70.06% |
| 2018 | 6.2 Billion JPY | -37.27% |
| 2017 | 9.88 Billion JPY | 16.44% |
| 2016 | 8.49 Billion JPY | -17.35% |
| 2015 | 10.27 Billion JPY | 23.28% |
| 2014 | 8.33 Billion JPY | -32.25% |
| 2013 | 12.3 Billion JPY | 58.5% |
| 2012 | 7.76 Billion JPY | 3.97% |
| 2011 | 7.46 Billion JPY | 15.5% |
| 2010 | 6.46 Billion JPY | -1.84% |
| 2009 | 6.58 Billion JPY | 2.99% |
| 2008 | 6.39 Billion JPY | 49.75% |
| 2007 | 4.26 Billion JPY | 61.4% |
| 2006 | 2.64 Billion JPY | 40.92% |
| 2005 | 1.87 Billion JPY | -65.97% |
| 2004 | 5.51 Billion JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -376 Million JPY | -117.42% |
| 2024 Q1 | 2.15 Billion JPY | 1558.11% |
| 2023 Q2 | 382 Million JPY | -76.61% |
| 2023 Q1 | 1.63 Billion JPY | 200.74% |
| 2023 FY | 4.01 Billion JPY | 455.8% |
| 2023 Q3 | 2.14 Billion JPY | 462.57% |
| 2023 Q4 | -148 Million JPY | -106.89% |
| 2022 Q1 | 130 Million JPY | 111.73% |
| 2022 FY | -1.12 Billion JPY | 19.47% |
| 2022 Q2 | -755 Million JPY | -680.77% |
| 2022 Q3 | 1.11 Billion JPY | 247.95% |
| 2022 Q4 | -1.62 Billion JPY | -245.12% |
| 2021 Q2 | -23 Million JPY | -107.85% |
| 2021 Q3 | -564 Million JPY | -2352.17% |
| 2021 FY | -1.4 Billion JPY | -193.16% |
| 2021 Q4 | -1.1 Billion JPY | -96.45% |
| 2021 Q1 | 293 Million JPY | 117.39% |
| 2020 Q1 | 1.63 Billion JPY | 285.15% |
| 2020 Q3 | 1.14 Billion JPY | 178.83% |
| 2020 FY | 1.5 Billion JPY | -18.96% |
| 2020 Q4 | -1.68 Billion JPY | -247.03% |
| 2020 Q2 | 411 Million JPY | -74.83% |
| 2019 Q1 | 2.06 Billion JPY | 67.29% |
| 2019 Q4 | -882 Million JPY | -317.78% |
| 2019 Q3 | 405 Million JPY | 48.35% |
| 2019 FY | 1.85 Billion JPY | -70.06% |
| 2019 Q2 | 273 Million JPY | -86.75% |
| 2018 FY | 6.2 Billion JPY | -37.27% |
| 2018 Q3 | 718 Million JPY | -43.38% |
| 2018 Q4 | 1.23 Billion JPY | 71.59% |
| 2018 Q1 | 2.98 Billion JPY | 108.09% |
| 2018 Q2 | 1.26 Billion JPY | -57.51% |
| 2017 FY | 9.88 Billion JPY | 16.44% |
| 2017 Q4 | 1.43 Billion JPY | -66.92% |
| 2017 Q3 | 4.33 Billion JPY | 88.07% |
| 2017 Q2 | 2.3 Billion JPY | 27.14% |
| 2017 Q1 | 1.81 Billion JPY | 140.77% |
| 2016 FY | 8.49 Billion JPY | -17.35% |
| 2016 Q1 | 3.32 Billion JPY | 441.92% |
| 2016 Q2 | 1.15 Billion JPY | -65.27% |
| 2016 Q3 | 3.26 Billion JPY | 183.17% |
| 2016 Q4 | 753 Million JPY | -76.94% |
| 2015 Q1 | 2.47 Billion JPY | 673.61% |
| 2015 Q3 | 6.2 Billion JPY | 141.66% |
| 2015 Q2 | 2.56 Billion JPY | 3.55% |
| 2015 Q4 | -971 Million JPY | -115.66% |
| 2015 FY | 10.27 Billion JPY | 23.28% |
| 2014 Q1 | 2.58 Billion JPY | 304.85% |
| 2014 FY | 8.33 Billion JPY | -32.25% |
| 2014 Q4 | -432 Million JPY | -112.48% |
| 2014 Q3 | 3.46 Billion JPY | 27.34% |
| 2014 Q2 | 2.71 Billion JPY | 5.06% |
| 2013 Q4 | 639 Million JPY | -90.63% |
| 2013 FY | 12.3 Billion JPY | 58.5% |
| 2013 Q1 | 3.17 Billion JPY | 404.78% |
| 2013 Q2 | 1.67 Billion JPY | -47.22% |
| 2013 Q3 | 6.81 Billion JPY | 307.59% |
| 2012 Q3 | 3.5 Billion JPY | 127.32% |
| 2012 FY | 7.76 Billion JPY | 3.97% |
| 2012 Q2 | 1.54 Billion JPY | -26.23% |
| 2012 Q1 | 2.08 Billion JPY | 106.83% |
| 2012 Q4 | 628 Million JPY | -82.07% |
| 2011 Q1 | 1.72 Billion JPY | 83.49% |
| 2011 FY | 7.46 Billion JPY | 15.5% |
| 2011 Q2 | 1.84 Billion JPY | 6.85% |
| 2011 Q3 | 2.89 Billion JPY | 57.03% |
| 2011 Q4 | 1.01 Billion JPY | -65.06% |
| 2010 Q4 | 939 Million JPY | -65.75% |
| 2010 Q1 | 2.06 Billion JPY | 1241.56% |
| 2010 FY | 6.46 Billion JPY | -1.84% |
| 2010 Q2 | 715 Million JPY | -65.39% |
| 2010 Q3 | 2.74 Billion JPY | 283.5% |
| 2009 Q2 | 2.18 Billion JPY | 29.54% |
| 2009 Q4 | 154 Million JPY | -93.98% |
| 2009 Q3 | 2.55 Billion JPY | 17.17% |
| 2009 Q1 | 1.68 Billion JPY | 0.36% |
| 2009 FY | 6.58 Billion JPY | 2.99% |
| 2008 Q2 | 581 Million JPY | 0.0% |
| 2008 FY | 6.39 Billion JPY | 49.75% |
| 2008 Q3 | 2.02 Billion JPY | 248.19% |
| 2008 Q4 | 1.68 Billion JPY | -16.96% |
| 2007 FY | 4.26 Billion JPY | 61.4% |
| 2006 FY | 2.64 Billion JPY | 40.92% |
| 2005 FY | 1.87 Billion JPY | -65.97% |
| 2004 FY | 5.51 Billion JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 5.11 Billion JPY | 21.436% |
| Takeda Pharmaceutical Company Limited | 214.07 Billion JPY | 98.124% |
| Sumitomo Pharma Co., Ltd. | -354.19 Billion JPY | 101.134% |
| Shionogi & Co., Ltd. | 171.46 Billion JPY | 97.657% |
| Wakamoto Pharmaceutical Co.,Ltd. | -195.51 Million JPY | 2154.616% |
| Nippon Shinyaku Co., Ltd. | 31.38 Billion JPY | 87.201% |
| Kaken Pharmaceutical Co., Ltd. | 9.51 Billion JPY | 57.774% |
| Eisai Co., Ltd. | 53.4 Billion JPY | 92.479% |
| Morishita Jintan Co., Ltd. | 716 Million JPY | -461.034% |
| Hisamitsu Pharmaceutical Co., Inc. | 13.16 Billion JPY | 69.492% |
| Mochida Pharmaceutical Co., Ltd. | 5.8 Billion JPY | 30.777% |
| Fuso Pharmaceutical Industries,Ltd. | 1.96 Billion JPY | -104.532% |
| Nippon Chemiphar Co., Ltd. | -494 Million JPY | 913.158% |
| Tsumura & Co. | 20.01 Billion JPY | 79.933% |
| Torii Pharmaceutical Co., Ltd. | 5.03 Billion JPY | 20.234% |
| Towa Pharmaceutical Co., Ltd. | 17.64 Billion JPY | 77.238% |
| Fuji Pharma Co., Ltd. | 3.85 Billion JPY | -4.121% |
| Zeria Pharmaceutical Co., Ltd. | 9.71 Billion JPY | 58.659% |
| KYORIN Holdings, Inc. | 6.01 Billion JPY | 33.195% |
| Taiko Pharmaceutical Co.,Ltd. | -3.07 Billion JPY | 230.464% |
| Daito Pharmaceutical Co.,Ltd. | 3.89 Billion JPY | -3.159% |
| SymBio Pharmaceuticals Limited | -811.66 Million JPY | 594.907% |
| MedRx Co., Ltd | -933 Million JPY | 530.547% |
| Mizuho Medy Co.,Ltd. | 5.15 Billion JPY | 22.03% |
| Solasia Pharma K.K. | -1.13 Billion JPY | 452.678% |
| Modalis Therapeutics Corporation | -2.37 Billion JPY | 269.494% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 6.5 Billion JPY | 38.2% |
| Sawai Group Holdings Co., Ltd. | 18.88 Billion JPY | 78.73% |
| Cyfuse Biomedical K.K. | -697.43 Million JPY | 675.966% |
| Toho Holdings Co., Ltd. | 19.33 Billion JPY | 79.22% |
| Koa Shoji Holdings Co.,Ltd. | 4.38 Billion JPY | 8.336% |